Corrigendum to "Increased serum levels of glutamate in adult patients with autism" [Progress in Neuro-Psychopharmacology & Biological Psychiatry 30 (2006) 1472--1477] (DOI:10.1016/j.pnpbp.2006.06.013);Increased serum levels of glutamate in adult patients with autism

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 30, Issue 8, 2006, Pages 1472-1477

  Shinohe, Atsuko ^a   Hashimoto, Kenji ^b   Nakamura, Kazuhiko ^a   Tsujii, Masatsugu ^c   Iwata, Yasuhide ^a   Tsuchiya, Kenji J ^a   Sekine, Yoshimoto ^a   Suda, Shiro ^a   Suzuki, Katsuaki ^a   Sugihara, Gen ichi ^a   Matsuzaki, Hideo ^a   Minabe, Yoshio ^a   Sugiyama, Toshiro ^d   Kawai, Masayoshi ^a   Iyo, Masaomi ^e   Takei, Nori ^a   Mori, Norio ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c CHUKYO UNIVERSITY   (Japan)

^d AICHI CHILDREN'S HEALTH AND MEDICAL CENTER   (Japan)

^e CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Amino acids; Autism; D Serine; Glutamate; HPLC; Human serum

Indexed keywords

DEXTRO SERINE; GLUTAMIC ACID; GLUTAMINE; GLYCINE; SERINE;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; AUTISM; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; NEUROTRANSMISSION; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGIC TEST; SCORING SYSTEM; SOCIAL ASPECT;

EID: 33750351298     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2006.11.001     Document Type: Erratum

References (48)

1. Aldred S., Moore K.M., Fitzgerald M., and Waring R.H. Plasma amino acid levels in children with autism and their families. J Autism Dev Disord 33 (2003) 93-97
2. Alfredsson G., Wiesel F.A., and Tylec A. Relationships between glutamate and monoamine metabolites in cerebrospinal fluid and serum in healthy volunteers. Biol Psychiatry 23 (1988) 689-697
3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed (1994) Washington, D.C.
4. Baron-Cohen S., and Belmonte M.K. Autism: a window onto the development of the social and the analytic brain. Annu Rev Neurosci 28 (2005) 109-126
5. Baron-Cohen S., O'Riordan M., Stone V., Jones R., and Plaisted K. Recognition of faux pas by normally developing children and children with Asperger syndrome or high-functioning autism. J Autism Dev Disord 29 (1999) 407-418
6. Blasi F., Bacchelli E., Carone S., Toma C., Monaco A.P., Bailey A.J., et al. International Molecular Genetic Study of Autism Consortium (IMGSAC). SLC25A12 and CMYA3 gene variants are not associated with autism in the IMGSAC multiplex family sample. Eur J Hum Genet 14 (2006) 123-126
7. Buss A.H., and Perry M. The Aggression Questionnaire. J Pers Soc Psychol 63 (1992) 452-459
8. Chuang D.M. Neuroprotective and neurotrophic actions of the mood stabilizer lithium: can it be used to treat neurodegenerative diseases?. Crit Rev Neurobiol 16 (2004) 83-90
9. Cohly H.H., and Panja A. Immunological findings in autism. Int Rev Neurobiol 71 (2005) 317-341
10. Coyle J.T., and Tsai G. The NMDA receptor glycine modulatory site: a therapeutic target for improving cognition and reducing negative symptoms in schizophrenia. Psychopharmacology (Berl) 174 (2004) 32-38
11. Coyle J.T., Leski M.L., and Morrison J.H. The diverse roles of l-glutamic acid in brain signal transduction. In: Davis K.L., Charney D., Coyle J.T., and Nemeroff C. (Eds). Neuropsychopharmacology-the fifth generation of progress (2002), Lippincott Williams & Wilkins, Philadelphia 71-90
12. Fukushima T., Kawai J., Imai K., and Toyo'oka T. Simultaneous determination of d- and l-serine in rat brain microdialysis sample using a column-switching HPLC with fluorimetric detection. Biomed Chromatogr 18 (2004) 813-819
13. Goodman W.K., Price L.H., Rasmussen S.A., Mazure C., Fleischmann R.L., Hill C.L., et al. The Yale-Brown Obsessive Compulsive Scale, I: development, use, and reliability. Arch Gen Psychiatry 46 (1989) 1006-1011
14. Goodman W.K., Price L.H., Rasmussen S.A., Mazure C., Delgado P., Heninger G.R., et al. The Yale-Brown Obsessive Compulsive Scale, II: validity. Arch Gen Psychiatry 46 (1989) 1012-1016
15. Hashimoto K., Fukushima T., Shimizu E., Komatsu N., Watanabe H., Shinoda N., et al. Decreased serum levels of d-serine in patients with schizophrenia: evidence in support of the NMDA receptor hypofunction hypothesis of schizophrenia. Arch Gen Psychiatry 60 (2003) 572-576
16. Hashimoto K., Shimizu E., and Iyo M. Dysfunction of glia-neuron communication in pathophysiology of schizophrenia. Curr Psychiatry Rev 1 (2005) 151-163
17. Hashimoto K., Engberg G., Shimizu E., Nordin C., Lindstrom L.H., and Iyo M. Elevated glutamine/glutamate ratio in cerebrospinal fluid of first episode and drug naive schizophrenic patients. BMC Psychiatry 5 (2005) 6
18. Hollander E., Dolgoff-Kaspar R., Cartwright C., Rawitt R., and Novotny S. An open trial of divalproex sodium in autism spectrum disorders. J Clin Psychiatry 62 (2001) 530-534
19. Jamain S., Betancur C., Quach H., Philippe A., Fellous M., Giros B., et al. Paris autism research international sibpair (PARIS) study linkage and association of the glutamate receptor 6 gene with autism. Mol Psychiatry 7 (2002) 302-310
20. Jyonouchi H., Sun S., and Itokazu N. Innate immunity associated with inflammatory responses and cytokine production against common dietary proteins in patients with autism spectrum disorder. Neuropsychobiology 46 (2002) 76-84
21. Jyonouchi H., Geng L., Ruby A., Reddy C., and Zimmerman-Bier B. Evaluation of an association between gastrointestinal symptoms and cytokine production against common dietary proteins in children with autism spectrum disorders. J Pediatr 146 (2005) 605-610
22. Jyonouchi H., Geng L., Ruby A., and Zimmerman-Bier B. Dysregulated innate immune responses in young children with autism spectrum disorders: their relationship to gastrointestinal symptoms and dietary intervention. Neuropsychobiology 51 (2005) 77-85
23. Kemper T.L., and Bauman M. Neuropathology of infantile autism. J Neuropathol Exp Neurol 57 (1998) 645-652
24. Kim P.M., Aizawa H., Kim P.S., Huang A.S., Wickramasinghe S.R., Kashani A.H., et al. Serine racemase: activation by glutamate neurotransmission via glutamate receptor interacting protein and mediation of neuronal migration. Proc Natl Acad Sci U S A 102 (2005) 2105-2110
25. Licinio J., Alvarado I., and Wong M.L. Autoimmunity in autism. Mol Psychiatry 7 (2002) 329
26. Lord C., Rutter M., and Le Couteur A. Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 24 (1994) 659-685
27. Manji H.K., and Lenox R.H. Signaling: cellular insights into the pathophysiology of bipolar disorder. Biol Psychiatry 48 (2000) 518-530
28. McDougle C.J., Erickson C.A., Stigler K.A., and Posey D.J. Neurochemistry in the pathophysiology of autism. J Clin Psychiatry 66 suppl 10 (2005) 9-18
29. McGale E.H., Pye I.F., Stonier C., Hutchinson E.C., and Aber G.M. Studies of the inter-relationship between cerebrospinal fluid and plasma amino acid concentrations in normal individuals. J Neurochem 29 (1977) 291-297
30. McNearney T., Baethge B.A., Cao S., Alam R., Lisse J.R., and Westlund K.N. Excitatory amino acids, TNF-α, and chemokine levels in synovial fluids of patients with active arthropathies. Clin Exp Immunol 137 (2004) 621-627
31. Meldrum B.S. The role of glutamate in epilepsy and other CNS disorders. Neurology 44 (1994) S14-S23
32. Moreno-Fuenmayor H., Borjas L., Arrieta A., Valera V., and Socorro-Candanoza L. Plasma excitatory amino acids in autism. Invest Clin 37 (1996) 113-128
33. Palmen S.J., van Engeland H., Hof P.R., and Schmitz C. Neuropathological findings in autism. Brain 127 (2004) 2572-2583
34. Plioplys A.V. Autism: electroencephalogram abnormalities and clinical improvement with valproic acid. Arch Pediatr Adolesc Med 148 (1994) 220-222
35. Polleux F., and Lauder J.M. Toward a developmental neurobiology of autism. Ment Retard Dev Disabil Res Rev 10 (2004) 303-317
36. Purcell A.E., Jeon O.H., Zimmerman A.W., Blue M.E., and Pevsner J. Postmortem brain abnormalities of the glutamate neurotransmitter system in autism. Neurology 57 (2001) 1618-1628
37. Rabionet R., McCauley J.L., Jaworski J.M., Ashley-Koch A.E., Martin E.R., Sutcliffe J.S., et al. Lack of association between autism and SLC25A12. Am J Psychiatry 163 (2006) 929-931
38. Ramoz N., Reichert J.G., Smith C.J., Silverman J.M., Bespalova I.N., Davis K.L., et al. Linkage and association of the mitochondrial aspartate/glutamate carrier SLC25A12 gene with autism. Am J Psychiatry 161 (2004) 662-669
39. Riikonen R. Neurotrophic factors in the pathogenesis of Rett syndrome. J Child Neurol 18 (2003) 693-697
40. Rolf L.H., Haarmann F.Y., Grotemeyer K.H., and Kehrer H. Serotonin and amino acid content in platelets of autistic children. Acta Psychiatr Scand 87 (1993) 312-316
41. Segurado R., Conroy J., Meally E., Fitzgerald M., Gill M., and Gallagher L. Confirmation of association between autism and the mitochondrial aspartate/glutamate carrier SLC25A12 gene on chromosome 2q31. Am J Psychiatry 162 (2005) 2182-2184
42. Serajee F.J., Zhong H., Nabi R., and Huq A.H. The metabotropic glutamate receptor 8 gene at 7q31: partial duplication and possible association with autism. J Med Genet 40 (2003) e42
43. Snyder S.H., and Ferris C.D. Novel neurotransmitters and their neuropsychiatric relevance. Am J Psychiatry 157 (2000) 1738-1751
44. Stone V.E., Baron-Cohen S., Calder A., Keane J., and Young A. Acquired theory of mind impairments in individuals with bilateral amygdala lesions. Neuropsychologia 41 (2003) 209-220
45. Tuchman R., and Rapin I. Epilepsy in autism. Lancet Neurol 1 (2002) 352-358
46. Volkmar F.R., and Nelson D.S. Seizure disorders in autism. J Am Acad Child Adolesc Psychiatry 29 (1990) 127-129
47. Volkmar F.R., and Pauls D. Autism. Lancet 362 (2003) 1133-1141
48. Yamada K., Ohnishi T., Hashimoto K., Ohba H., Iwayama-Shigeno Y., Toyoshima M., et al. Identification of multiple serine racemase (SRR) mRNA isoforms and genetic analyses of SRR and DAO in schizophrenia and d-serine levels. Biol Psychiatry 57 (2005) 1493-1503